Enigma Therapeutics India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Months 17 Days
About Enigma Therapeutics India
Enigma Therapeutics India Private Limited (ETIPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 20 February 2024 ( 11 months 17 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Saidul Rahaman and Jonathan Ahmet serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U86905TS2024FTC182406
-
Company No.
182406
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
20 Feb 2024
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Who are the key members and board of directors at Enigma Therapeutics India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saidul Rahaman
|
Director | 20-Feb-2024 | Current |
Jonathan Ahmet
|
Director | 20-Feb-2024 | Current |
Financial Performance of Enigma Therapeutics India.
Enhance accessibility to Enigma Therapeutics India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Enigma Therapeutics India?
Unlock access to Enigma Therapeutics India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Hinova Data Centre Cooling Private LimitedSaidul Rahaman is a mutual person
-
Iseinko Pharma Private Limited
Saidul Rahaman is a mutual person
-
Chandrapur Medicinal Seeds Private Limited
Saidul Rahaman is a mutual person
-
Yukapar Textiles Private Limited
Saidul Rahaman is a mutual person
-
Dat Innovations Private Limited
Saidul Rahaman is a mutual person
-
Etenhub Private Limited
Saidul Rahaman is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Enigma Therapeutics India?
Enigma Therapeutics India has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Enigma Therapeutics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enigma Therapeutics India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.